Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin‑induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway-Reference-Cited by-同舟云学术

Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin‑induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway

Published:2018-07-20 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Yu Zi‑Kai¹,Yang Bin²,Zhang Yu¹,Li Liu‑Sheng¹,Zhao Jin‑Ning³,Hao Wei³

Affiliation:

1. Department of Nephropathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China

2. Department of Pathology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China

3. Experimental Research Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways;Journal of Ethnopharmacology;2024-03

2. Protective effect of modified Huangqi Chifeng decoction ((sic)(sic)(sic)(sic) (sic)(sic)(sic)) on immunoglobulin A nephropathy through toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway;J TRADIT CHIN MED;2024

3. Analysis of the alleviating effect of modified Huangqi Chifeng decoction on rats with focal segmental glomerulosclerosis based on gut microbiota and fecal metabolomics;Journal of Applied Microbiology;2023-09

4. Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: A mechanism review;Biomedicine & Pharmacotherapy;2022-12

5. VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway;BMC Nephrology;2022-09-16